Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Rheumatology
•
Systemic lupus erythematosus
•
Neurology
•
Neuro-immunology
•
lupus
•
Neuropsychiatric Lupus
What is your treatment approach to neuropsychiatric symptoms secondary to lupus?
Related Questions
What is your workup and treatment approach for cranial neuropathies in patients with lupus?
In a patient with strong serologic evidence of SLE presenting with isolated bilateral lower limb sensorimotor neuropathy, normal neuroimaging, and CSF, would you initiate cyclophosphamide with pulse-dose steroids upfront, or reserve escalation (e.g., plasma exchange or immunosuppressants) for cases refractory to steroids?
How do you approach new-onset idiopathic intracranial hypertension (IIH) with someone who has history of systemic lupus erythematosus?
What are your vaccine recommendations while patients are on biologics?
Should patients starting cyclophosphamide be screened routinely for latent tuberculosis (TB)?
What is your initial treatment paradigm for someone with both CNS and peripheral neurologic Sjogren’s?
Would you accept the diagnosis of SLE on the basis of an AVISE CTD panel where the results just showed a positive EC4d or BC4d, positive ANA>1/80 + one clinical criteria such as multiple tender joints but did otherwise not fulfill criteria for SLE?
What is the clinical significance of a low titer RNP, negative Sm, but Sm/RNP that is very high titer?
Do you generally prefer to continue hydroxychloroquine in lupus patients who develop ESRD despite the low likelihood of clinically active disease in this patient population?
What is the role of inebilizumab in the maintenance treatment of IgG4-related disease?